Dr. Holmes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Colchester Ave
Second floor ACC
Burlington, VT 05401Phone+1 802-847-8400
Education & Training
- University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- University of Vermont Medical CenterResidency, Internal Medicine, 1997 - 2000
- University of Virginia School of MedicineClass of 1997
Certifications & Licensure
- VT State Medical License 1997 - 2026
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Treatment Trial for Post-Thrombotic Syndrome Start of enrollment: 2008 Mar 01
- The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy Start of enrollment: 2008 Jul 01
- Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 496 citationsThe platelet contribution to cancer progression.N. M. Bambace, Chris E. Holmes
Journal of Thrombosis and Haemostasis. 2011-02-01 - 96 citationsPlatelets, coagulation and fibrinolysis in breast cancer progressionInder Lal, Kim Dittus, Chris E. Holmes
Breast Cancer Research. 2013-07-31 - 44 citationsCorrelates of Anemia in American Blacks and Whites The REGARDS Renal Ancillary StudyNeil A. Zakai, Leslie A. McClure, Ronald J. Prineas, George Howard, William M. McClellan
American Journal of Epidemiology. 2008-12-09
Abstracts/Posters
- Post Discharge Risk of Venous Thromboembolism in a Primary Care PopulationChris E. Holmes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis PreventionChris E. Holmes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- UVM Cancer Center Rolls Out Custom-Made ImmunotherapyFebruary 22nd, 2023
- Holcombe Named Director of UVM Cancer Center and Chief of Hematology/OncologyApril 13th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: